Feb 26, 2021 — Rozanolixizumab (UCB7665) is a monoclonal antibody that acts by selectively binding FcRn, leading to reduced levels of circulating ...
rozanolixizumab-ucb
3925e8d270
rozanolixizumab, rozanolixizumab fda approval, rozanolixizumab ucb, rozanolixizumab phase 3, rozanolixizumab itp, rozanolixizumab cidp, rozanolixizumab mechanism of action, rozanolixizumab approval, rozanolixizumab dosing, rozanolixizumab wiki